Brain+ lands first large-pharma partnership deal to enter the German market for dementia products
BRAIN+ A/S (BRAINP) Company Announcement No. 4-2021 Wednesday, December 15, 2021, 8:20 CET The information communicated in this announcement is “inside information” for the purposes of article 7 of the Market Abuse Regulation 596/2014 Brain+ has signed a partnership agreement with RoX Health , a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.Germany is the largest and most interesting EU market to Brain+: More than 1.5 million people are living with dementia in Germany. With new and